What's New
Emma Heming Willis Honored with Caregiving Award
Emma Heming Willis was recently honored by Maria Shriver’s Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic, receiving the organization’s Caregiving Award for her “outstanding work in advocating for unpaid family…
Session Videos from AFTD’s 2025 Education Conference Now Available
Sessions from AFTD’s 2025 Education Conference are now available on our YouTube channel. Whether you missed a session, you weren’t able to join us live in Denver or virtually, or…
Study Identifies Profile of Blood-Based Inflammatory Proteins as Potential FTD Biomarker
A study published in the journal Brain earlier this year identified a profile of inflammation-related proteins that could potentially serve as a FTD biomarker gauging the severity of the disease.…
Tips & Advice – Navigating FTD-ALS
In 2011, researchers discovered that variants of the C9orf72 gene are the most common cause of both genetic FTD and amyotrophic lateral sclerosis (ALS). Nevertheless, it is important to recognize…
Coya Therapeutics Reports Positive Interim Results in Clinical Trial for Experimental FTD Therapy
Coya Therapeutics announced positive interim results for its clinical trial for a potentially disease-modifying treatment course for FTD, citing data showing that it helped to prevent cognitive decline. Therapeutics Address…
AviadoBio Announces Completion of Second Cohort in ASPIRE-FTD Trial at AFTD Education Conference
Gene therapy company AviadoBio announced the completion of the second cohort of its phase 1/2 clinical trial of a potential genetic FTD treatment at the 2025 AFTD Annual Education Conference…
Celebrating 20 Years of AFTD’s Pilot Grant Program
Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock…
Celebrating 20 Years of AFTD’s Pilot Grant Program
Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock…
Advancing Hope: FTD and ALS Joint Initiatives
Did you know that certain cellular changes that occur in FTD are also observed in Amyotrophic Lateral Sclerosis (ALS)? In some cases, neurodegeneration in ALS and FTD is linked to…
The Lived Experience of FTD: Managing Anxiety
The following article was written by Chris Tann, a member of AFTD’s Persons With FTD Advisory Council. You can learn more about Chris and the other members of the Council…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)